Follicular Lymphoma
Follicular Lymphoma
The latest news, research, and perspectives in follicular lymphoma (FL).
Advertisement
Melissa BadamoAggressive B-Cell Lymphoma | May 27, 2025
Steady access to Medicaid insurance helps ensure early recognition of symptoms, said senior author Xu Ji, PhD.
Andrew MorenoAggressive B-Cell Lymphoma | May 23, 2025
The global phase 3 RCT is part of an sBLA for glofitamab plus gemcitabine and oxaliplatin use in R/R DLBCL NOS.
Nichole TuckerTransplantation & Cellular Therapy | May 29, 2025
Axi-cel shows durable response in high-risk LBCL frontline treatment with 80% progression-free at 3 years in ZUMA-12 trial.
Melissa BadamoAcute Lymphoblastic Leukemia | May 16, 2025
Studies have shown that oncologists are leaving the workforce at increasing rates in association with growing workloads.
Melissa BadamoAcute Lymphoblastic Leukemia | May 8, 2025
LucyRx’s pharmacy network includes Northwestern Medicine Specialty Pharmacy, Dana Farber Cancer Institute, and more..
Andrew MorenoAggressive B-Cell Lymphoma | April 30, 2025
Efficacy and safety profile data were presented at the AACR Annual Meeting 2025.
Advertisement
Andrew MorenoTransplantation & Cellular Therapy | April 25, 2025
The ASCO Association Board Chair has written letters to the new heads of the CMS, FDA, and NIH.
Melissa BadamoAcute Lymphoblastic Leukemia | April 23, 2025
The Community Oncology Alliance outlined solutions for Congress to address systemic challenges of the U.S. healthcare system.
Melissa BadamoPrint | April 14, 2025
The award provides early-career researchers at NCCN Member Institutions with $150,000 in funding to support cancer research.
Nirav Shah, MD, MSHPTransplantation & Cellular Therapy | April 15, 2025
Nirav Shah, MD, MSHP, recently presented at the International Ultmann Chicago Lymphoma Symposium on this subject.
Melissa BadamoVideo Insights | April 15, 2025
Nicholas Freedman, DO, presented on symptom management and supportive care at the Tri-State Blood Cancer Conference.
Melissa BadamoAcute Lymphoblastic Leukemia | April 8, 2025
More than 240 meetings were held with members of Congress as part of the ASCO 10th Annual Advocacy Summit.
Sarah Rutherford, MDFollicular Lymphoma | April 9, 2025
Some major themes for practice include identifying patients at risk for early progression and emphasis on quality of life.
Melissa BadamoAcute Lymphoblastic Leukemia | March 14, 2025
Melody Smith, MD, MS, shares data on burnout in hematologist oncologists, why it occurs, and how to prevent it.
Andrew MorenoMyeloma | March 10, 2025
This orally available, selective inhibitor of XPO1 is the first agent of its kind to receive commercialization approval.
Andrew MorenoAggressive B-Cell Lymphoma | March 14, 2025
A panel moderated by Neil Love, MD, explored clinical data to assess these treatment approaches for the various types of NHL.
Ruemu Birhiray, MDFollicular Lymphoma | April 7, 2025
With insights into next-generation therapies, this discussion explores what’s ahead in the follicular lymphoma landscape.
Ruemu Birhiray, MDFollicular Lymphoma | April 7, 2025
Ruemu Birhiray, MD of Hematology Oncology of Indiana leads the continuation of a roundtable discussion on FL treatment.
Ruemu Birhiray, MDFollicular Lymphoma | April 7, 2025
Three experts analyze data on combination therapy for FL, including efficacy, safety, and strategy adoption.
Andrew MorenoFollicular Lymphoma | February 26, 2025
Clinical evaluations of this bispecific antibody as monotherapy or in polytherapy for B-cell non-Hodgkin lymphomas continue.
Advertisement
Advertisement